This entry was posted on Monday, June 25th, 2007 at 12:03 am and is filed under Health, Health News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
GPHub.com World News
Medicine, medication and health news from around the World.
Amylin, Lilly: BYETTA Shows Comparable Glucose Control To Insulin - CNNMoney.com
Author: Google News25.06.2007
 CNNMoney.com |
CNNMoney.com -
Amylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY) said study results comparing treatment with BYETTA injection and insulin glargine treatment in people with type 2 diabetes showed comparable improvements in blood sugar control, ...
Amylin, Lilly: Byetta Cuts Hypoglycemia Risk
Amylin And Eli Lilly Reveal Results Comparing Treatment With ...